Seneca Biopharma Current Assets

Seneca Biopharma (SNCA) currently reports a current assets of $13M as of December 2020. That compares with $5.6M in the prior-year period — up 128.1% year over year. Use the charts on this page to explore Seneca Biopharma's current assets history and peer comparisons.

Seneca Biopharma's current assets increased from $5.6M to $13M — a 128.1% year-over-year increase (period ending December 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Seneca Biopharma reported $13M in current assets as of December 2020. That compares with $5.6M in the prior-year period — up 128.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Seneca Biopharma, and consider following SNCA for alerts when major investors trade the stock.

Seneca Biopharma is classified in the Healthcare sector. On current assets, it currently shows $13M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SNCA with unrelated industries.